比较糖尿病药物——有助于临床决策吗？ - Suppr

Suppr

超能文献

Comparing diabetes drugs--helping clinical decisions?

作者信息

Thethi Tina, Fonseca Vivian

机构信息

Southeast Louisiana Veterans Health Care System, New Orleans, LA, USA.

出版信息

Lancet. 2013 Jan 12;381(9861):93-4. doi: 10.1016/S0140-6736(12)61576-1. Epub 2012 Nov 7.

DOI:10.1016/S0140-6736(12)61576-1

PMID:23141811

Abstract

摘要

相似文献

Comparing diabetes drugs--helping clinical decisions?

Lancet. 2013 Jan 12;381(9861):93-4. doi: 10.1016/S0140-6736(12)61576-1. Epub 2012 Nov 7.

GLP-1 receptor agonists for type 2 diabetes.

Lancet. 2009 Jul 4;374(9683):4-6. doi: 10.1016/S0140-6736(09)60942-9. Epub 2009 Jun 8.

Glucagon-like peptide-1 analogues for type 2 diabetes.

BMJ. 2011 Feb 16;342:d410. doi: 10.1136/bmj.d410.

Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability.

Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S279-84. doi: 10.2337/dc11-s231.

Insulin avoidance and treatment outcomes among patients with a professional driving licence starting glucagon-like peptide 1 (GLP-1) agonists in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits.

Diabet Med. 2012 May;29(5):690-2. doi: 10.1111/j.1464-5491.2011.03475.x.

Emerging treatments for patients with type 2 diabetes.

Diabetes Educ. 2007 May-Jun;33 Suppl 5:105S-10S. doi: 10.1177/0145721707302S885.

Liraglutide for type 2 diabetes?

Drug Ther Bull. 2010 May;48(5):50-3. doi: 10.1136/dtb.2010.01.0006.

Diabetes treatment and measures of glycemia.

Diabetes Care. 2009 Apr;32(4):e39-43. doi: 10.2337/dc09-zb04.

Glucagon-like peptide-1 agonists.

BMJ. 2012 Jan 10;344:d7282. doi: 10.1136/bmj.d7282.

Integrating incretin-based therapy into type 2 diabetes management.

J Fam Pract. 2013 Jun;62(6 Suppl CME):S1-8.

引用本文的文献

Update on Safety Issues Related to Antihyperglycemic Therapy.

Diabetes Spectr. 2014 May;27(2):92-100. doi: 10.2337/diaspect.27.2.92.

Personalizing guidelines for diabetes management: twilight or dawn of the expert?

BMC Med. 2013 Jul 10;11:161. doi: 10.1186/1741-7015-11-161.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Comparing diabetes drugs--helping clinical decisions?

Lancet. 2013 Jan 12;381(9861):93-4. doi: 10.1016/S0140-6736(12)61576-1. Epub 2012 Nov 7.

GLP-1 receptor agonists for type 2 diabetes.

Lancet. 2009 Jul 4;374(9683):4-6. doi: 10.1016/S0140-6736(09)60942-9. Epub 2009 Jun 8.

Glucagon-like peptide-1 analogues for type 2 diabetes.

BMJ. 2011 Feb 16;342:d410. doi: 10.1136/bmj.d410.

Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability.

Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S279-84. doi: 10.2337/dc11-s231.

Diabet Med. 2012 May;29(5):690-2. doi: 10.1111/j.1464-5491.2011.03475.x.

Emerging treatments for patients with type 2 diabetes.

Diabetes Educ. 2007 May-Jun;33 Suppl 5:105S-10S. doi: 10.1177/0145721707302S885.

Liraglutide for type 2 diabetes?

Drug Ther Bull. 2010 May;48(5):50-3. doi: 10.1136/dtb.2010.01.0006.

Diabetes treatment and measures of glycemia.

Diabetes Care. 2009 Apr;32(4):e39-43. doi: 10.2337/dc09-zb04.

Glucagon-like peptide-1 agonists.

BMJ. 2012 Jan 10;344:d7282. doi: 10.1136/bmj.d7282.

Integrating incretin-based therapy into type 2 diabetes management.

J Fam Pract. 2013 Jun;62(6 Suppl CME):S1-8.

引用本文的文献

Update on Safety Issues Related to Antihyperglycemic Therapy.

Diabetes Spectr. 2014 May;27(2):92-100. doi: 10.2337/diaspect.27.2.92.

Personalizing guidelines for diabetes management: twilight or dawn of the expert?

BMC Med. 2013 Jul 10;11:161. doi: 10.1186/1741-7015-11-161.